VSee Health, Inc. announced on September 24, 2025, that it was notified by The Nasdaq Stock Market LLC in a letter dated September 15, 2025, that the Nasdaq Hearings Panel granted the company's request for continued listing on Nasdaq. This decision provides a reprieve from the earlier delisting notice.
The continued listing is subject to specific conditions. VSee Health must evidence compliance with Nasdaq's periodic reporting requirement by filing its Q1 and Q2 Quarterly Reports on Form 10-Q for periods ending March 31, 2025, and June 30, 2025, respectively, by October 15, 2025.
Additionally, the company is required to demonstrate compliance with the Equity Rule by December 1, 2025. While this approval removes the immediate threat of delisting, the company remains under strict deadlines to address its financial reporting deficiencies and maintain compliance.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.